Novel and Emerging Trends in Cancer Chemotherapy
Start with the big picture
A central theme in contemporary cancer treatment is matching therapy to molecular features of a tumor. Genomic profiling and companion diagnostics can help identify actionable alterations, while immune checkpoint inhibitors aim to restore antitumor T-cell activity. Other approaches redirect or engineer immune cells, deliver cytotoxic payloads to selected targets, or act on particular mutations and cellular pathways. The topic also introduces emerging strategies such as oncolytic viruses, protein degradation, tumor-microenvironment targeting, nanomedicine, and radioligand therapy. Together, these developments illustrate how cancer treatment is expanding toward more selective and biologically informed options. The full lesson organizes these approaches by treatment class and discusses representative examples and mechanisms.
What you'll learn
- Explain how tumor genomic profiling can guide precision oncology.
- Describe how checkpoint inhibitors aim to restore antitumor immune activity.
- Distinguish CAR-T therapy, BiTEs, oncolytic viruses, and antibody–drug conjugates.
- Identify examples of targeted therapies and the pathways or alterations they address.
- Recognize emerging strategies involving protein degradation, the tumor microenvironment, and drug delivery.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
